Katalin Karászi

15.3k total citations
22 papers, 615 citations indexed

About

Katalin Karászi is a scholar working on Molecular Biology, Obstetrics and Gynecology and Cell Biology. According to data from OpenAlex, Katalin Karászi has authored 22 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Obstetrics and Gynecology and 6 papers in Cell Biology. Recurrent topics in Katalin Karászi's work include Pregnancy and preeclampsia studies (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Liver physiology and pathology (4 papers). Katalin Karászi is often cited by papers focused on Pregnancy and preeclampsia studies (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Liver physiology and pathology (4 papers). Katalin Karászi collaborates with scholars based in Hungary, United States and United Kingdom. Katalin Karászi's co-authors include Ilona Kovalszky, Zoltán Papp, Kornélia Baghy, Nándor Gábor Than, Tibor Füle, Alexandra Fullár, Roberto Romero, Péter Hollósi, József Dudás and Gábor Sobel and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Katalin Karászi

22 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katalin Karászi Hungary 13 230 208 154 131 131 22 615
Marcella Falchetti Italy 16 225 1.0× 231 1.1× 107 0.7× 274 2.1× 97 0.7× 19 803
Shu Soeda Japan 14 144 0.6× 180 0.9× 106 0.7× 205 1.6× 126 1.0× 67 702
Ritsuto Fujiwaki Japan 17 357 1.6× 206 1.0× 206 1.3× 215 1.6× 90 0.7× 55 834
Joan Murphy Canada 16 281 1.2× 274 1.3× 165 1.1× 162 1.2× 64 0.5× 22 910
Kyung Jin Eoh South Korea 19 335 1.5× 246 1.2× 259 1.7× 240 1.8× 47 0.4× 60 934
Hideaki Yahata Japan 15 268 1.2× 544 2.6× 80 0.5× 190 1.5× 62 0.5× 70 1.1k
Diana P. English United States 14 183 0.8× 216 1.0× 85 0.6× 275 2.1× 53 0.4× 31 676
Jamal Rahaman United States 18 315 1.4× 522 2.5× 230 1.5× 163 1.2× 64 0.5× 52 1.3k
Adriaan Vanderstichele Belgium 14 288 1.3× 43 0.2× 327 2.1× 300 2.3× 93 0.7× 29 752

Countries citing papers authored by Katalin Karászi

Since Specialization
Citations

This map shows the geographic impact of Katalin Karászi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katalin Karászi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katalin Karászi more than expected).

Fields of papers citing papers by Katalin Karászi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katalin Karászi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katalin Karászi. The network helps show where Katalin Karászi may publish in the future.

Co-authorship network of co-authors of Katalin Karászi

This figure shows the co-authorship network connecting the top 25 collaborators of Katalin Karászi. A scholar is included among the top collaborators of Katalin Karászi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katalin Karászi. Katalin Karászi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karászi, Katalin, Bálint Péterfia, Lilla Turiák, et al.. (2022). SPOCK1 Promotes the Development of Hepatocellular Carcinoma. Frontiers in Oncology. 12. 819883–819883. 9 indexed citations
2.
Tóth, Gábor, et al.. (2021). Alterations in protein expression and site-specific N-glycosylation of prostate cancer tissues. Scientific Reports. 11(1). 15886–15886. 11 indexed citations
3.
Reszegi, Andrea, Katalin Karászi, Gábor Tóth, et al.. (2021). Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice. Cancers. 13(7). 1548–1548. 7 indexed citations
4.
Németh, Kinga, Katalin Mészáros, Nikolette Szücs, et al.. (2020). Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior. The Journal of Clinical Endocrinology & Metabolism. 105(6). 2015–2026. 7 indexed citations
5.
Karászi, Katalin, et al.. (2020). Aberrant Expression of Syndecan-1 in Cervical Cancers. Pathology & Oncology Research. 26(4). 2255–2264. 10 indexed citations
6.
Hollósi, Péter, Katalin Karászi, Bálint Péterfia, et al.. (2020). Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1. Biomolecules. 10(10). 1356–1356. 6 indexed citations
7.
Fullár, Alexandra, Katalin Karászi, Péter Hollósi, et al.. (2020). Two ways of epigenetic silencing of TFPI2 in cervical cancer. PLoS ONE. 15(6). e0234873–e0234873. 13 indexed citations
8.
Reszegi, Andrea, Zsolt Horváth, Katalin Karászi, et al.. (2020). The Protective Role of Decorin in Hepatic Metastasis of Colorectal Carcinoma. Biomolecules. 10(8). 1199–1199. 14 indexed citations
11.
Karászi, Katalin, Andrea Reszegi, András Kiss, et al.. (2019). Syndecan-1 in Liver Diseases. Pathology & Oncology Research. 26(2). 813–819. 24 indexed citations
12.
Sápi, Zoltàn, Miklós Garami, G Papp, et al.. (2017). The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors. Pathology & Oncology Research. 25(1). 217–224. 14 indexed citations
13.
Grolmusz, Vince Kornél, Katalin Karászi, Tamás Micsík, et al.. (2016). Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer.. PubMed. 6(9). 2041–2053. 50 indexed citations
14.
Fullár, Alexandra, József Dudás, Péter Hollósi, et al.. (2015). Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. BMC Cancer. 15(1). 256–256. 111 indexed citations
15.
Szabo, S., Meera Mody, Roberto Romero, et al.. (2015). Activation of Villous Trophoblastic p38 and ERK1/2 Signaling Pathways in Preterm Preeclampsia and HELLP Syndrome. Pathology & Oncology Research. 21(3). 659–668. 33 indexed citations
16.
Tarish, Firas, Niklas Schultz, Anna Tanoglidi, et al.. (2015). Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair. Science Translational Medicine. 7(312). 312re11–312re11. 63 indexed citations
17.
Kerr, Martin, Helen E. Scott, Blaž Grošelj, et al.. (2014). Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer. Clinical Cancer Research. 20(21). 5435–5445. 18 indexed citations
18.
Szabo, S., Yi Xu, Roberto Romero, et al.. (2013). Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 463(3). 445–458. 42 indexed citations
19.
Than, Nándor Gábor, Roberto Romero, Hamutal Meiri, et al.. (2011). PP13, Maternal ABO Blood Groups and the Risk Assessment of Pregnancy Complications. PLoS ONE. 6(7). e21564–e21564. 45 indexed citations
20.
Várkonyi, Tibor, B. Nagy, Tibor Füle, et al.. (2010). Microarray Profiling Reveals That Placental Transcriptomes of Early-onset HELLP Syndrome and Preeclampsia Are Similar. Placenta. 32. S21–S29. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026